Recludix Pharma Presents Preclinical Data Demonstrating Stro

Recludix Pharma Presents Preclinical Data Demonstrating Strong Efficacy and Favorable Safety Profile of REX-7117 Versus TYK2 and JAK Inhibitors at the Dermatology Drug Development Summit

Recludix Pharma Presents Preclinical Data Demonstrating Strong Efficacy and Favorable Safety Profile of REX-7117 Versus TYK2 and JAK Inhibitors at the Dermatology Drug Development Summit

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Nancy Whiting , Aljanae Reynolds , Recludix Pharma , Alexandra Santos , Paul Smith , Recludix Pharma Inc , Dermatology Drug Development Summit , Ground Between Safety Efficacy In Drug Development , Annual Dermatology Drug Development Summit , New Ground Between Safety , Drug Development ,